Published in FEMS Microbiol Lett on May 15, 2004
Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev (2007) 15.82
Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev (2005) 15.72
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother (2008) 2.97
"Stormy waters ahead": global emergence of carbapenemases. Front Microbiol (2013) 2.74
Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother (2005) 1.99
Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil. Antimicrob Agents Chemother (2009) 1.75
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother (2008) 1.60
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain. Antimicrob Agents Chemother (2009) 1.44
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.36
BEL-1, a novel clavulanic acid-inhibited extended-spectrum beta-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2005) 1.34
Integron-encoded GES-type extended-spectrum beta-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2005) 1.34
GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrob Agents Chemother (2010) 1.29
Mechanistic basis for the emergence of catalytic competence against carbapenem antibiotics by the GES family of beta-lactamases. J Biol Chem (2009) 1.28
First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum beta-lactamases in Korea. Antimicrob Agents Chemother (2005) 1.24
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases. Antimicrob Agents Chemother (2010) 1.17
Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods. Front Microbiol (2016) 1.07
Nomenclature of GES-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother (2005) 1.01
Evaluation of the BYG Carba Test, a New Electrochemical Assay for Rapid Laboratory Detection of Carbapenemase-Producing Enterobacteriaceae. J Clin Microbiol (2015) 0.96
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2010) 0.93
GES-18, a new carbapenem-hydrolyzing GES-Type β-lactamase from Pseudomonas aeruginosa that contains Ile80 and Ser170 residues. Antimicrob Agents Chemother (2012) 0.92
Emergence of Escherichia coli sequence type ST131 carrying both the blaGES-5 and blaCTX-M-15 genes. Antimicrob Agents Chemother (2011) 0.91
Identification of products of inhibition of GES-2 beta-lactamase by tazobactam by x-ray crystallography and spectrometry. J Biol Chem (2011) 0.91
Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 β-lactamases. Antimicrob Agents Chemother (2012) 0.87
Carbapenem-hydrolyzing GES-5-encoding gene on different plasmid types recovered from a bacterial community in a sewage treatment plant. Appl Environ Microbiol (2011) 0.86
Characterization of pKP-M1144, a Novel ColE1-Like Plasmid Encoding IMP-8, GES-5, and BEL-1 β-Lactamases, from a Klebsiella pneumoniae Sequence Type 252 Isolate. Antimicrob Agents Chemother (2015) 0.85
Importance of position 170 in the inhibition of GES-type β-lactamases by clavulanic acid. Antimicrob Agents Chemother (2011) 0.83
Pyrosequencing as a rapid tool for identification of GES-type extended-spectrum beta-lactamases. J Clin Microbiol (2006) 0.82
Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand. PLoS One (2015) 0.82
Kinetic and structural requirements for carbapenemase activity in GES-type β-lactamases. Biochemistry (2014) 0.79
A report on the presence of GES-5 extended spectrum beta-lactamase producing Pseudomonas aeruginosa associated with urinary tract infection from north-east India. Indian J Med Res (2014) 0.75
Whole genome sequencing of ESBL-producing Escherichia coli isolated from patients, farm waste and canals in Thailand. Genome Med (2017) 0.75
Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother (2003) 5.75
Replicon typing of plasmids encoding resistance to newer beta-lactams. Emerg Infect Dis (2006) 3.75
Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-beta-lactamase VIM-1. Antimicrob Agents Chemother (2003) 3.22
Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int J Antimicrob Agents (2007) 2.61
Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother (2014) 2.18
Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother (2009) 2.12
An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10). J Antimicrob Chemother (2011) 2.03
Novel variant (bla(VIM-4)) of the metallo-beta-lactamase gene bla(VIM-1) in a clinical strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2002) 2.00
IS26-associated In4-type integrons forming multiresistance loci in enterobacterial plasmids. Antimicrob Agents Chemother (2005) 1.63
An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant. Antimicrob Agents Chemother (2010) 1.40
Multilocus sequence typing of IncN plasmids. J Antimicrob Chemother (2011) 1.39
VIM-12, a novel plasmid-mediated metallo-beta-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid. Antimicrob Agents Chemother (2005) 1.22
VIM-1 metallo-beta-lactamase in Acinetobacter baumannii. Emerg Infect Dis (2006) 1.18
Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases. Antimicrob Agents Chemother (2009) 1.17
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases. Antimicrob Agents Chemother (2010) 1.17
Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase. Int J Antimicrob Agents (2012) 1.16
Multidrug and broad-spectrum cephalosporin resistance among Salmonella enterica serotype enteritidis clinical isolates in southern Italy. J Clin Microbiol (2002) 1.14
Outbreak of infections caused by Enterobacter cloacae producing the integron-associated beta-lactamase IBC-1 in a neonatal intensive care unit of a Greek hospital. Antimicrob Agents Chemother (2002) 1.13
Relative strengths of the class 1 integron promoter hybrid 2 and the combinations of strong and hybrid 1 with an active p2 promoter. Antimicrob Agents Chemother (2008) 1.12
Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 beta-lactamases. J Antimicrob Chemother (2007) 1.05
Emergence of Klebsiella pneumoniae of a novel sequence type (ST383) producing VIM-4, KPC-2 and CMY-4 β-lactamases. Int J Antimicrob Agents (2010) 1.02
Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective. Expert Rev Anti Infect Ther (2012) 0.99
Expanded-spectrum cephalosporin-resistant salmonella strains in Romania. J Clin Microbiol (2002) 0.96
Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals. Int J Antimicrob Agents (2011) 0.95
Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification. BMC Infect Dis (2012) 0.95
Detection of metallo-β-lactamase genes in clinical specimens by a commercial multiplex PCR system. J Microbiol Methods (2010) 0.94
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli. Antimicrob Agents Chemother (2007) 0.93
Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons. BMC Infect Dis (2013) 0.92
CMY-42, a novel plasmid-mediated CMY-2 variant AmpC beta-lactamase. Microb Drug Resist (2011) 0.90
Analysis of emergence of quinolone-resistant gonococci in Greece by combined use of Neisseria gonorrhoeae multiantigen sequence typing and multilocus sequence typing. J Clin Microbiol (2011) 0.90
Successful control of a neonatal outbreak caused mainly by ST20 multidrug-resistant SHV-5-producing Klebsiella pneumoniae, Greece. BMC Pediatr (2014) 0.89
Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase. J Antimicrob Chemother (2010) 0.87
Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece. Med Sci Monit (2008) 0.87
Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests. Antimicrob Agents Chemother (2008) 0.86
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase. Antimicrob Agents Chemother (2009) 0.84
Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece. J Antimicrob Chemother (2008) 0.84
Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases. J Antimicrob Chemother (2012) 0.83
Correlation between bacterial indicators and bacteriophages in sewage and sludge. FEMS Microbiol Lett (2006) 0.83
OmpK35 and OmpK36 porin variants associated with specific sequence types of Klebsiella pneumoniae. J Chemother (2013) 0.82
Interactions of oximino-substituted boronic acids and β-lactams with the CMY-2-derived extended-spectrum cephalosporinases CMY-30 and CMY-42. Antimicrob Agents Chemother (2012) 0.82
Confronting carbapenemase-producing Klebsiella pneumoniae. Future Microbiol (2013) 0.82
Effects of the Val211Gly substitution on molecular dynamics of the CMY-2 cephalosporinase: implications on hydrolysis of expanded-spectrum cephalosporins. Proteins (2011) 0.81
In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints. Diagn Microbiol Infect Dis (2010) 0.81
Changing figures of antimicrobial susceptibility and serovar distribution in Neisseria gonorrhoeae isolated in Greece. Sex Transm Dis (2010) 0.80
Emergence of NDM-producing Klebsiella pneumoniae in Greece. Diagn Microbiol Infect Dis (2013) 0.80
Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004. J Antimicrob Chemother (2006) 0.79
A multiresistant Klebsiella pneumoniae clinical isolate carrying both CTX-M-15 and VIM-1 beta-lactamases, harboured by different plasmids. Int J Antimicrob Agents (2008) 0.78
Prevalence and characterization of the mechanisms of macrolide, lincosamide and streptogramin resistance in viridans group streptococci. Int J Antimicrob Agents (2003) 0.77
Comment on: Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother (2009) 0.75
Supplementation of growth media with Zn2+ facilitates detection of VIM-2-producing Pseudomonas aeruginosa. J Clin Microbiol (2008) 0.75
Klebsiella pneumoniae: Virulence, Biofilm and Antimicrobial Resistance. Pediatr Infect Dis J (2017) 0.75
Klebsiella pneumoniae. Pediatr Infect Dis J (2017) 0.75
Epidemiology of multiresistant Enterococcus avium isolates in a Greek tertiary care hospital. Int J Antimicrob Agents (2002) 0.75
Characterisation of CTX-M-117, a Pro174Gln variant of CTX-M-15 extended-spectrum β-lactamase, from a bovine Escherichia coli isolate. Int J Antimicrob Agents (2012) 0.75